Sanjay Mehta, M.D.

And around the same time is when prostate radiation started becoming a thing. But at the time, radical prostatectomy was obviously still king. But now in the 2020s, I think prostate has taken off and it's probably close to matching breast cancer now. Those are number one and number two. But we also do, depending on where you are in the country and what you're

And around the same time is when prostate radiation started becoming a thing. But at the time, radical prostatectomy was obviously still king. But now in the 2020s, I think prostate has taken off and it's probably close to matching breast cancer now. Those are number one and number two. But we also do, depending on where you are in the country and what you're

affiliation with the hospital is tons of CNS, lung, lymphoma, GI, not colon, but more rectal and anal distal GI cancers. Even in the pediatric world, we try to avoid radiating children, but it's a very big part of that as well. So we use it for almost all types of cancer now, actually, all solid tumors anyway.

affiliation with the hospital is tons of CNS, lung, lymphoma, GI, not colon, but more rectal and anal distal GI cancers. Even in the pediatric world, we try to avoid radiating children, but it's a very big part of that as well. So we use it for almost all types of cancer now, actually, all solid tumors anyway.

Fisher's big study in the 80s, which now we have 40 year data from that. And it's interesting how now even the modified radicals are relatively rare. We still have some advanced cases that they have to go that route. But we see tons and tons of patients now who are so much happier. Their quality of life is much better by just having a simple lumpectomy, a central node biopsy.

Fisher's big study in the 80s, which now we have 40 year data from that. And it's interesting how now even the modified radicals are relatively rare. We still have some advanced cases that they have to go that route. But we see tons and tons of patients now who are so much happier. Their quality of life is much better by just having a simple lumpectomy, a central node biopsy.

And if it's all negative, especially if they've had their mammograms, you get a small T1 or T2 tumor. We give radiation to the whole breast following that. And the radiation is, again, fractionated into small daily bits. They'll get somewhere in the neighborhood of, these days, it's actually only about three weeks of treatment, maybe about, I say, 40 gray in roughly 15 fractions.

And if it's all negative, especially if they've had their mammograms, you get a small T1 or T2 tumor. We give radiation to the whole breast following that. And the radiation is, again, fractionated into small daily bits. They'll get somewhere in the neighborhood of, these days, it's actually only about three weeks of treatment, maybe about, I say, 40 gray in roughly 15 fractions.

We used to give, even when I was in a couple of decades ago, we were giving 50 to 60 gray. It was quite a bit higher dose. But to 40 gray in 15 fractions to the full breast, and with the modern technology, we can cover the breast tissue without significant heart or lung dose.

We used to give, even when I was in a couple of decades ago, we were giving 50 to 60 gray. It was quite a bit higher dose. But to 40 gray in 15 fractions to the full breast, and with the modern technology, we can cover the breast tissue without significant heart or lung dose.

We can even use tangential beams, even if it's a left-sided tumor, to stay away from the heart, which is things that we couldn't do very well in the past. The overall and disease-free survivals are pretty much comparable to someone who had a modified radical.

We can even use tangential beams, even if it's a left-sided tumor, to stay away from the heart, which is things that we couldn't do very well in the past. The overall and disease-free survivals are pretty much comparable to someone who had a modified radical.

Fantastic book and one of your best podcasts. Love that guy. Yeah, he's a legend.

Fantastic book and one of your best podcasts. Love that guy. Yeah, he's a legend.

Yes, in a more advanced case. But if it's a typical T1 or even a small T2 that we see, they may not need any neoadjuvant therapy. They just will If it's, like I say, a one and a half centimeter mass that's easily resectable, they'll remove that just without any neoadjuvant treatment.

Yes, in a more advanced case. But if it's a typical T1 or even a small T2 that we see, they may not need any neoadjuvant therapy. They just will If it's, like I say, a one and a half centimeter mass that's easily resectable, they'll remove that just without any neoadjuvant treatment.

And we'll do adjuvant radiation and then potentially, depending on the receptor status, adjuvant hormone therapy, which is the domain of the medical oncologist, but we still work with them. So just surgery followed by three to four weeks of radiation. How long after surgery can you begin radiation? Wound healing, we give them a little bit of time.

And we'll do adjuvant radiation and then potentially, depending on the receptor status, adjuvant hormone therapy, which is the domain of the medical oncologist, but we still work with them. So just surgery followed by three to four weeks of radiation. How long after surgery can you begin radiation? Wound healing, we give them a little bit of time.

We generally do our CT-based simulation and three-dimensional planning maybe two to three weeks after their surgery. And then by the time, it takes about a week to do all of our computer programming, and then we'll start the treatment within three to four weeks post-op.

We generally do our CT-based simulation and three-dimensional planning maybe two to three weeks after their surgery. And then by the time, it takes about a week to do all of our computer programming, and then we'll start the treatment within three to four weeks post-op.